World's Best Scientists 2026 revealed!
Manal F. Abdelmalek

Manal F. Abdelmalek

D-Index & Metrics

Medicine

D-Index
91
Citations
44780
World Ranking
11547
National Ranking
5922

Overview

Manal F. Abdelmalek is affiliated with the Mayo Clinic in the United States and has a substantial body of work primarily focused on medicine with a strong emphasis on hepatology and related disciplines.

The main fields of study covered in their research include:

  • Medicine

Subfields of study include:

  • Epidemiology
  • Hepatology
  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Surgery

The scientist's primary research topics address various aspects of liver diseases and metabolism. These topics are:

  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Diet, Metabolism, and Disease
  • Liver Diseases and Immunity
  • Pancreatitis Pathology and Treatment
  • Diet and metabolism studies
  • Hepatitis C virus research

Manal F. Abdelmalek's recent publications reflect active involvement in defining and guiding the clinical understanding of fatty liver disease. Notable recent papers include:

  • "MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease," 2020, Gastroenterology
  • "A multisociety Delphi consensus statement on new fatty liver disease nomenclature," 2023, Hepatology
  • "A multisociety Delphi consensus statement on new fatty liver disease nomenclature," 2023, Journal of Hepatology
  • "AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease," 2023, Hepatology
  • "A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis," 2024, New England Journal of Medicine

Frequent co-authors in their collaborative work include:

  • Arun J. Sanyal
  • Rohit Loomba
  • Stephen A. Harrison
  • Anna Mae Diehl
  • Sven Francque

Publications featuring Manal F. Abdelmalek commonly appear in the following venues:

  • Journal of Hepatology
  • Hepatology
  • Gastroenterology
  • Clinical Gastroenterology and Hepatology
  • Hepatology Communications

Best Publications

  • MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.

    Mohammed Eslam;Arun J Sanyal;Jacob George

  • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    Brent A Neuschwander-Tetri;Rohit Loomba;Arun J Sanyal;Joel E Lavine

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Fructose consumption as a risk factor for non-alcoholic fatty liver disease

    Xiaosen Ouyang;Pietro Cirillo;Yuri Sautin;Shannon McCall

  • Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.

    Manal F. Abdelmalek;Ayako Suzuki;Cynthia Guy;Aynur Unalp-Arida

  • Fructose and sugar: A major mediator of non-alcoholic fatty liver disease

    Thomas Jensen;Manal F. Abdelmalek;Shelby Sullivan;Kristen J. Nadeau

  • Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.

    Amedeo Lonardo;Fabio Nascimbeni;Stefano Ballestri;De Lisa Fairweather

  • A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis

    Scott L. Friedman;Vlad Ratziu;Stephen A. Harrison;Manal F. Abdelmalek

  • Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

    Manal F Abdelmalek;Paul Angulo;Roberta A Jorgensen;Pamela B Sylvestre

  • Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.

    Arun Sanyal;Edgar D Charles;Brent A Neuschwander-Tetri;Rohit Loomba

  • Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.

    Mohammad S. Siddiqui;Raj Vuppalanchi;Mark L. Van Natta;Erin Hallinan

  • Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

    Elizabeth M. Brunt;David E. Kleiner;Laura A. Wilson;Aynur Unalp

  • A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.

    Sven M Francque;Pierre Bedossa;Vlad Ratziu;Quentin M Anstee

  • Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease

    Mark L. Palmeri;Michael H. Wang;Ned C. Rouze;Manal F. Abdelmalek

  • Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

    Zobair M. Younossi;Rohit Loomba;Quentin M. Anstee;Mary Eugenia Rinella

  • NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

    Stephen A Harrison;Mary E Rinella;Manal F Abdelmalek;James F Trotter

  • Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.

    Susan K. Murphy;Hyuna Yang;Cynthia A. Moylan;Herbert Pang

  • No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial.

    Arun J. Sanyal;Manal F. Abdelmalek;Ayako Suzuki;Oscar W. Cummings

  • Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

    Zobair M. Younossi;Rohit Loomba;Mary E. Rinella;Elisabetta Bugianesi

  • Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.

    Fasiha Kanwal;Fasiha Kanwal;Jay H. Shubrook;Leon A. Adams;Kim Pfotenhauer

Frequent Co-Authors

Anna Mae Diehl
Anna Mae Diehl Duke University
Rohit Loomba
Rohit Loomba University of California, San Diego
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
Zachary Goodman
Zachary Goodman Inova Fairfax Hospital
Brent A. Neuschwander-Tetri
Brent A. Neuschwander-Tetri Saint Louis University
Kris V. Kowdley
Kris V. Kowdley Washington State University
Naga Chalasani
Naga Chalasani Indiana University
David R. Nelson
David R. Nelson University of Tennessee Health Science Center
Joel E. Lavine
Joel E. Lavine Columbia University
Stephen H. Caldwell
Stephen H. Caldwell University of Virginia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a medical career in the USA opens the door to a variety of related online degrees and career pathways. For those interested in mental health, pursuing an msn to pmhnp online can lead to rewarding roles as a Psychiatric Mental Health Nurse Practitioner, expanding your expertise and career options.

Another popular direction is healthcare management. Comparing healthcare administration degree cost is essential, as these degrees prepare you for vital administrative roles while offering flexibility for working professionals.

Pursuing advanced leadership in healthcare? Discover the cheapest mha programs to find affordable Master’s in Healthcare Administration degrees that can lead to high-level supervisory positions in hospitals and clinics.

Nurses seeking a terminal degree can explore the best online bsn to dnp programs, which offer comprehensive clinical training with the flexibility of online learning. Each of these pathways offers unique advancement opportunities in medicine without the traditional classroom setting.

Best Scientists Citing Manal F. Abdelmalek

Trending Scientists

Recently Published Articles